checkAd

Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap

(PLX AI) – Biomerieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solutionSays will acquire 100% ownership of Specific Diagnostics for an …

  • (PLX AI) – Biomerieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution
  • Says will acquire 100% ownership of Specific Diagnostics for an acquisition price equivalent to 3.3% of bioMérieux market capitalization as of April 11
  • Says acquisition price will be paid with a combination of cash and shares issued to certain Specific Diagnostics shareholders
  • The issuance of new bioMérieux shares shall result in a share dilution of approximately 1%
  • Says to launch a share buyback program, post-closing, to offset this share dilution over time


Wertpapier



0 Kommentare
Autor: PLX AI
 |  1323   |   |   

Schreibe Deinen Kommentar

Disclaimer

Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap (PLX AI) – Biomerieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solutionSays will acquire 100% ownership of Specific Diagnostics for an …

Nachrichten des Autors

Titel
Titel
Titel
Titel